Image in public domain.

A team of researchers in South Korea has turned an ordinary-looking contact lens into a device that can stimulate the brain through the eye. In mice, the lens reduced depression-like behavior so strongly that its effects were comparable to fluoxetine, the active ingredient in Prozac.

While this is far from an actual treatment, the study hints at a tantalizing possibility: that the eye may become a non-invasive gateway for treating brain disorders.

“Our work opens up an entirely new frontier of treating brain disorders through the eye,” Jang-Ung Park, one of the study authors and a scientist at Yonsei University, notes.

The eye is the window to the brain

Depression treatments still come with major trade-offs. Antidepressants can take weeks to work and often fail in many patients. Electroconvulsive therapy can be effective, especially in severe depression, but it requires anesthesia and remains heavily stigmatized. Deep brain stimulation goes even further, requiring electrodes implanted inside the skull.

Scientists have long wanted a way to stimulate mood-related brain circuits without surgery. The hard part is reaching the right circuits safely and precisely. This is where the eyes come in.

AI-generated image (not from the study).

The new study tries to solve that problem through the retina. The retina sits inside the eye, but developmentally and anatomically, it is part of the central nervous system. It is also connected to brain pathways involved in mood, stress, and emotional regulation.

“Because the eye is anatomically a part of the brain, we wondered whether a simple contact lens could serve as a gentle, non-invasive doorway to brain circuits that control mood,” Park said. 

To build that doorway, the team embedded ultrathin electrodes inside a soft contact lens. The electrodes were made from layers of gallium oxide and platinum just a few nanometers thick. The wiring followed a snaking pattern, allowing it to stretch and bend as the lens moved.

The researchers also coated the stimulation sites with platinum nanoclusters. This lowered electrical resistance and helped the device transfer charge more efficiently into tissue. Even after the electronics were molded into the curved lens, the device remained more than 80% transparent across visible wavelengths.

Then, they started testing it.

How the lens stimulates the brain

The system uses a technique called temporal interference stimulation. Rather than sending one strong electrical pulse, the lens delivers two harmless high-frequency electrical signals into the retina at slightly different frequencies. 

On their own, the signals are too fast to strongly activate neurons. But where they overlap, they generate a slower “envelope” wave that can stimulate nerve cells. In this study, the researchers used signals that produced a 20-hertz interference pattern. Park compared the idea to two flashlights.

“Think of two flashlights: each beam alone is dim, but where they overlap, a bright spot appears, and that bright spot can be created far away from the flashlights themselves. Our contact lens does the same with two harmless electrical signals,” Park explained.

This approach gives the system a major advantage over conventional electrical stimulation, which often activates tissue near the electrodes in a less controlled way. 

In the new lens, the strongest stimulation occurred precisely in the intended retinal region, helping the researchers selectively activate eye-brain circuits associated with mood regulation.

Testing the lenses on depressed mice

To test the idea, the team used mice exposed to corticosterone, a stress hormone commonly used to induce depression-like symptoms in animal studies. These mice showed behaviors associated with anxiety, reduced movement, social withdrawal, and helplessness.

The mice showed behaviors associated with anxiety, hopelessness, reduced movement, and social withdrawal. The team divided the animals into several groups: healthy mice, untreated depressed mice, depressed mice treated with contact lenses, and depressed mice given fluoxetine.

The best-performing setup delivered a 20-hertz interference signal at 200 millivolts for 30 minutes per day over three weeks.

The treated mice became more active in open-field tests and spent more time exploring the center of an enclosure, a common sign of reduced anxiety-like behavior in rodents. Compared with untreated mice, the stimulated group showed a 76% increase in movement and a 132% increase in time spent in the center area.

In tail suspension and forced swim tests, which are commonly used to measure depression-like helplessness in rodents, the stimulation reduced immobility by roughly half. The mice also became more social, showing more interest in unfamiliar mice.

Across multiple behavioral tests, the improvements were comparable to those seen in mice treated with fluoxetine.

The lenses also changed the brain itself

The researchers didn’t stop at behavior. They wanted to know whether the treatment was actually restoring damaged brain function.

Using implanted neural probes, the team recorded electrical activity between the hippocampus and prefrontal cortex — two brain regions heavily involved in mood and cognition. Depression is known to weaken communication between these regions.

After treatment, the contact-lens-stimulated mice showed restored synchronization between the two areas, particularly in low-frequency theta brain waves associated with emotional processing and memory. Neural coherence between the regions rose sharply, approaching levels seen in healthy mice.

The biological changes were equally important. For instance, depression had reduced the density of dendritic spines — tiny neuronal structures essential for communication between brain cells. The stimulation reversed much of that damage, restoring nearly half of the lost spine density.

The treatment also reduced inflammation markers strongly associated with depression. Stress hormone levels also improved. Blood corticosterone dropped by 48%, while serotonin levels increased by about 47% compared with untreated depressed mice.

Moreover, to test whether all these changes collectively resembled recovery, the researchers used a machine-learning system trained on behavioral, neural, and biological data. The algorithm consistently grouped the treated mice closer to healthy mice than to untreated depressed mice.

A futuristic idea with major limitations

The technology, known as the temporal-interference-based transcorneal electrical stimulation (TI-TES), is still far from human use.

“Although this study has a solid theoretical foundation and interesting results, its scope is limited to preclinical analysis and, therefore, cannot be extrapolated to routine clinical practice. Nevertheless, this work represents a novel starting point that suggests avenues to explore for treating this condition,” noted Naia Sáez, a psychiatrist from the University of Barcelona not associated with the study.

For one thing, mouse models of depression are limited. They can mimic some behaviors linked to depression, but they do not capture the full human disorder. Independent experts also stressed that the results cannot yet be extrapolated to clinical practice and that human trials will be needed to test both safety and effectiveness.

There are also engineering problems. Human eyes move constantly. Contact lenses can irritate the eye or raise infection risks. The device would need to become wireless, reliable, comfortable, and safe over long periods. It would also need to work in healthy eyes without disrupting vision.

Still, the work opens an unusual new path for brain therapy: stimulating mood-related circuits through the eye instead of implanting electrodes deep inside the brain. 

If successful, the technology could turn ordinary-looking contact lenses into one of the least invasive tools ever designed for directly influencing the brain. It could even have other exciting applications, concludes Gerard Anmella, a psychiatrist at the University of Barcelona not associated with the study.

“Even so, this work opens a door that was hard to imagine just a few years ago: stimulating the deep brain using electrical currents delivered through contact lenses. And, if the technology matures, it could be applied to other brain-related disorders and diseases. One might even consider its potential as a cognitive enhancer in the society we live in and are moving toward—with all the ethical questions that would raise,” notes Anmella.

The study is published in the journal Cell Reports Physical Science.